glp 1 therapy for diabetes The Benefits of GLP-1 Therapy: Beyond Weight Loss GLP-1 Injections for Medical Weight
Description
When gut bacteria break down soluble fiber and resistant starch, they produce short-chain fatty acids that may interact with receptors on L-cells involved in hormone signaling
Lebedeva FOCUS
Retatrutide, a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors, represents a groundbreaking advancement in obesity and T2DM pharmacotherapy
In these medications, liraglutide and semaglutide have demonstrated remarkable efficacy in clinical trials, leading to substantial weight reductions (Pi-Sunyer et al 2015
Biomolecules (2022) 12(10):1338
E.MyintA
